Nader Davari1, Fatemeh Ahmadpour2, Ali Asghar Kiani3,4, Mozhgan Azadpour5, Zari Tahannejad Asadi6,7. 1. Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 2. Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 3. Department of Hematology and Blood Transfusion, Lorestan University, Khoramabad, Iran. 4. Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. 5. Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. 6. Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Aztahannjad@yahoo.com. 7. Department of Laboratory Sciences, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Aztahannjad@yahoo.com.
Abstract
OBJECTIVE: In chronic lymphocytic leukemia (CLL), lack of expression or dysregulation of some special miRs disrupts apoptosis of malignant cells; thereby miR expression can enhance cell proliferation, disease progression and decrease patient survival. RESULTS: 30 CLL patients and 20 healthy individuals participated in the study. RNA was extracted to evaluate the expression of miR-125, miR-223, BCL-2 and signal transducer and transcription 3 activator (STAT3) genes; quantitative Real Time- PCR (Q-RT-PCR) was performed. MiR-125a and miR-223 expression decreased in the patients compared to the control group (P-Value:0.001). BCL-2 and STAT3 which are the target genes of these two miRs, showed increased expression, in the patients compared to the control subjects (P-Value: 0.001 and P-Value: 0.64 respectively). A significant reverse relationship was found between miR-125a and BCl-2 expression and WBC count. Significantly, miR-223 expression was associated with smoking in patients (P-Value: 0.007). Also, these miRs may have regulatory effects by controlling white blood cell (WBC) production based on the inverse correlation with WBC count and hemoglobin (Hb) concentration. Finally, miR-223 can be used as a prognostic factor in CLL patients; miR-125a may be useful for evaluating the therapeutic approaches based on the inverse link with BCl-2.
OBJECTIVE: In chronic lymphocytic leukemia (CLL), lack of expression or dysregulation of some special miRs disrupts apoptosis of malignant cells; thereby miR expression can enhance cell proliferation, disease progression and decrease patient survival. RESULTS: 30 CLL patients and 20 healthy individuals participated in the study. RNA was extracted to evaluate the expression of miR-125, miR-223, BCL-2 and signal transducer and transcription 3 activator (STAT3) genes; quantitative Real Time- PCR (Q-RT-PCR) was performed. MiR-125a and miR-223 expression decreased in the patients compared to the control group (P-Value:0.001). BCL-2 and STAT3 which are the target genes of these two miRs, showed increased expression, in the patients compared to the control subjects (P-Value: 0.001 and P-Value: 0.64 respectively). A significant reverse relationship was found between miR-125a and BCl-2 expression and WBC count. Significantly, miR-223 expression was associated with smoking in patients (P-Value: 0.007). Also, these miRs may have regulatory effects by controlling white blood cell (WBC) production based on the inverse correlation with WBC count and hemoglobin (Hb) concentration. Finally, miR-223 can be used as a prognostic factor in CLL patients; miR-125a may be useful for evaluating the therapeutic approaches based on the inverse link with BCl-2.
Authors: Yi Hu; Chun-Mei Liu; Lu Qi; Tian-Zhu He; Liu Shi-Guo; Chan-Juan Hao; Yi Cui; Ning Zhang; Hong-Fei Xia; Xu Ma Journal: RNA Biol Date: 2011-07-26 Impact factor: 4.652
Authors: Holger Schulz; Julia F Bohlius; Sven Trelle; Nicole Skoetz; Marcel Reiser; Thilo Kober; Guido Schwarzer; Michael Herold; Martin Dreyling; Michael Hallek; Andreas Engert Journal: J Natl Cancer Inst Date: 2007-05-02 Impact factor: 13.506
Authors: Basile Stamatopoulos; Nathalie Meuleman; Benjamin Haibe-Kains; Pascale Saussoy; Eric Van Den Neste; Lucienne Michaux; Pierre Heimann; Philippe Martiat; Dominique Bron; Laurence Lagneaux Journal: Blood Date: 2009-01-14 Impact factor: 22.113